New drug aims to supercharge immune system against tough cancers
Disease control
Recruiting now
This early-stage trial tests a new drug called QXL138AM in about 100 people with advanced solid tumors (like ovarian, pancreatic, or lung cancer) or multiple myeloma. The drug is designed to help the immune system attack cancer cells. The main goal is to check safety and find the…
Phase: PHASE1 • Sponsor: Nammi Therapeutics Inc • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC